APLT NASDAQ
Applied Therapeutics, Inc.
1W: -13.6%
1M: -58.5%
3M: -85.7%
1Y: -88.3%
3Y: -87.5%
5Y: -99.6%
$0.10
Last traded 2025-12-31 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Revenue Segmentation
By Product / Service
Revenue by Segment (5-Year Trend)
Income Trends
Revenue
$455K
-95.4% ▼
Gross Profit
-$48M
-95.4% ▼
Operating Income
-$104M
-61.6% ▼
Net Income
-$106M
+11.8% ▲
EPS (Diluted)
$-0.76
+46.5% ▲
EBITDA
-$104M
-61.8% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $10M | $455K |
| YoY Growth | +0.0% | +0.0% | +0.0% | +0.0% | -95.4% |
| Cost of Revenue | $0 | $0 | $441K | $54M | $49M |
| Gross Profit | $0 | $0 | -$441K | -$44M | -$48M |
| Gross Margin | — | — | — | -439.4% | -10613.0% |
| R&D Expenses | $62M | $63M | $56M | $54M | $49M |
| SG&A Expenses | $33M | $43M | $27M | $21M | $56M |
| Operating Expenses | $94M | $106M | $83M | $21M | $56M |
| Operating Income | -$94M | -$106M | -$83M | -$65M | -$104M |
| Operating Margin | — | — | — | -645.8% | -22922.9% |
| Interest Expense | $559K | $555K | $0 | $0 | $0 |
| Income Before Tax | -$94M | -$106M | -$83M | -$120M | -$106M |
| Tax Expense | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$94M | -$106M | -$83M | -$120M | -$106M |
| Net Margin | — | — | — | -1198.5% | -23214.1% |
| EPS (Diluted) | $-4.28 | $-4.12 | $-2.18 | $-1.42 | $-0.76 |
| EBITDA | -$94M | -$106M | -$82M | -$65M | -$104M |
| Shares Outstanding | 22M | 26M | 38M | 84M | 140M |